New combo therapy aims to shrink Hard-to-Treat tumors
Disease control
Recruiting now
This study tests a new drug called EVM14, given alone or with another drug (pembrolizumab), in people with advanced solid tumors that have spread or come back. The main goals are to check safety and see if the treatment can control or shrink tumors. About 94 adults with certain t…
Phase: PHASE1, PHASE2 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC